| Tabah, Azah A; Tardif, Keith; Mansky, Louis M (2014) Anti-HIV-1 activity of Trim 37. J Gen Virol 95:960-7 |
| Dapp, Michael J; Bonnac, Laurent; Patterson, Steven E et al. (2014) Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. J Virol 88:354-63 |
| Clouser, Christine L; Bonnac, Laurent; Mansky, Louis M et al. (2014) Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antivir Chem Chemother 23:223-30 |
| Holtz, Colleen M; Mansky, Louis M (2013) Variation of HIV-1 mutation spectra among cell types. J Virol 87:5296-9 |
| Dapp, Michael J; Patterson, Steven E; Mansky, Louis M (2013) Back to the future: revisiting HIV-1 lethal mutagenesis. Trends Microbiol 21:56-62 |
| Holtz, Colleen M; Sadler, Holly A; Mansky, Louis M (2013) APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure. Nucleic Acids Res 41:6139-48 |
| Dapp, Michael J; Heineman, Richard H; Mansky, Louis M (2013) Interrelationship between HIV-1 fitness and mutation rate. J Mol Biol 425:41-53 |
| Rawson, Jonathan M; Heineman, Richard H; Beach, Lauren B et al. (2013) 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorg Med Chem 21:7222-8 |
| Greggs 3rd, Willie M; Clouser, Christine L; Patterson, Steven E et al. (2012) Discovery of drugs that possess activity against feline leukemia virus. J Gen Virol 93:900-5 |
| Dapp, Michael J; Holtz, Colleen M; Mansky, Louis M (2012) Concomitant lethal mutagenesis of human immunodeficiency virus type 1. J Mol Biol 419:158-70 |
Showing the most recent 10 out of 20 publications
